Sialylated human apolipoprotein E (apoE(s)) is preferentially associated with neuron-enriched cultures from APOE transgenic mice

Neurobiology of Disease

Volumn 6, Issue 1, 1999, Pages 63-75

  Xu, Pu Ting ^a   Schmechel, Donald ^a,b   Qiu, Hui Ling ^a   Herbstreith, Michael ^a   Rothrock Christian, Tracie ^a   Eyster, Michele ^a   Roses, Allen D ^a   Gilbert, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; IMMUNOREACTIVITY; MOUSE; MYELINATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION; TRANSGENIC MOUSE;

EID: 0032892741     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1998.0213     Document Type: Article

References (33)

1. Alberts M., Graffagnino C., McClenny C., Strittmatter W., Delong D., Saunders A., Roses A. ApoE genotype and survival from intracerebral hemorrhage. Lancet. 346:1995;575.
2. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., Taylor J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513.
3. Brewer G. J., Torricelli J. R., Evege E. K., Price P. J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
4. Colton C. A., Pagan F., Snell J., Cummins A., Gilbert D. L. Protection from oxidation enhances the survival of cultured mesencephalic neurons. Exp. Neurol. 132:1995;54-56.
5. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late-onset families. Science. 261:1993;921-923.
6. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7:1994;180-184.
7. Han S-H., Hulette C., Saunders A., Einstein G., Pericak-Vance M., Strittmatter W., Roses A., Schmechel D. Apolipoprotein E is present in hippocampal neurons without neuro-fibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128:1994a;13-26.
8. Han S-H, Einstein G., Weisgraber K., Strittmatter W., Saunders A., Pericak-Vance M., Roses A., Schmechel D. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:1994b;535-544.
9. Horsburgh K., Fitzpatrick M., Nilsen M., Nicoll J. A. R. Marked alterations in the cellular localization and levels of apolipoprotein E following acute subdural hematoma in rat. Brain Res. 763:1997;103-110.
10. Hulette C. M., Welsh-Bohmer K. A., Szymanski M. H., Sinclaire N. O., Roses A. D. Rapid brain autopsy. Arch. Pathol. Lab. Med. 121:1997;615-618.
11. Ignatius M. J., Gebicke-Harter P. J., Skene J. H. P., Schilling J. W., Weisgraber K. H., Mahley R. W., Shooter E. M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
12. Jain R. S., Quarfordt S. H. The carbohydrate content of apolipoprotein E from human very low density lipoproteins. Life Sci. 25:1979;1315-1324.
13. Krul E. S., Cole T. G. Quantitation of apolipoprotein E. Methods Enzymol. 263:1996;170-187.
14. Linton M. F., Gish R., Hubl S. T., Butler E., Esquivel C., Bry W. I., Boyles J. K., Wardell M. R., Young S. G. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88:1991;270-281.
15. Mahley R. W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
16. 3. Brain Res. 593:1992;307-310.
17. Muller H. W., Gebicke-Harter P. J., Hangen D. H., Shooter E. M. A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science. 228:1985;499-501.
18. Piedrahita J. A., Zhang S. H., Hagaman J. R., Oliver P. M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
19. Pitas R. E., Boyles J. K., Lee S. H., Hui D., Weisgraber K. H. Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262:1987;14352-14360.
20. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
21. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron. 11:1993;575-580.
22. Saunders A. M., Strittmatter W. J., Schmechel D., St George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Albert M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele β4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
23. Schmechel D., Tiller O., Tong P., McSwain M., Han S-H, Ange R., Burkhart D., Izard M. Pattern of apolipoprotein E immunoreactivity during brain aging. Apolipoprotein E and Alzheimer's Disease. 1996;Fondation IPSEN, Springer-Verlag. p. 27-48.
24. Skene J. H. P., Shooter E. M. Denervated sheath cells secrete a new protein after nerve injury. Proc. Natl. Acad. Sci. USA. 80:1983;4169-4173.
25. Snipes G. J., McGuire C. B., Norden J. J., Freeman J. A. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc. Natl. Acad. Sci. USA. 83:1986;1130-1134.
26. Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., Quarfordt S. H., Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272:1997;17972-17980.
27. Tardiff B. E., Newman M. F., Saunders A. M., Strittmatter W. J., Blumenthal J. A., White W. D., Croughwell N. D., Davis R. D., Roses A. D., Reves J. G. Preliminary report of genetic basis for cognitive decline after cardiac operations. Ann Thorac. Surg. 64:1997;715-720.
28. Weisgraber K. H. Apolipoprotein E: Structure-function relationships. Adv. Protein Chem. 45:1994;249-302.
29. Xu P.-T., Schmechel D., Rothrock-Christian T., Burkhart D. S., Qiu H.-L., Popko B., Sulllivan P., Maeda N., Saunders A. M., Roses A. D., Gilbert J. R. Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: Human-like pattern of glialand. Neurobiol. Disease. 3:1996;229-245.
30. Xu P.-T., Gilbert J. R., Qiu H.-L., Rothrock-Christian T., Settles D. L., Roses A. D., Schmechel D. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci. Lett. 246:1998a;65-68.
31. Xu P.-T., Gilbert J. R., Qiu H. L., Ervin J., Hulette C., Schmechel D. E. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 1998b.
32. Zannis V. I., Breslow J. L. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry. 20:1981;1033-1041.
33. Zannis V. I., VanderSpek J., Silverman D. Molecular modifications of human apolipoprotein E. J. Biol. Chem. 261:1986;13415-13421.